Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Circulating Cell Free Mitochondrial DNA As a Diagnostic and Prognostic Biomarker in Chronic and Late Acute Graft-Versus-Host Disease in Children

Shima Azadpour, Sayeh Abdossamadi, Bernard Ng, Elena Ostroumov, Geoff D.E. Cuvelier, Kirk R. Schultz

Blood (2022) 140 (Supplement 1): 12864.

DOI: https://doi.org/10.1182/blood-2022-165431

Published: 2022

Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

Blood (2022) 140 (Supplement 1): 8146–8149.

DOI: https://doi.org/10.1182/blood-2022-158338

Published: 2022

Journal Articles

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Blood (2022) 139 (2): 287–299.

DOI: https://doi.org/10.1182/blood.2021013244

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Blood (2021) 138 (Supplement 1): 3880.

DOI: https://doi.org/10.1182/blood-2021-148652

Published: 2021

Journal Articles

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation

Muna Qayed, Kwang Woo Ahn, Carrie L. Kitko, Mariam H. Johnson, Nirali N. Shah, Christopher Dvorak, Karin Mellgren, Brian D. Friend, Michael R. Verneris, Wing Leung, Jacek Toporski, John Levine, Joseph Chewning, Alan Wayne, Urvi Kapoor, Brandon Triplett, Kirk R. Schultz, Gregory A. Yanik, Mary Eapen

Blood (2021) 137 (7): 983–993.

DOI: https://doi.org/10.1182/blood.2020009342

Published: 2021

Journal Articles

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Blood (2020) 136 (Supplement 1): 11–12.

DOI: https://doi.org/10.1182/blood-2020-139031

Published: 2020

Journal Articles

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Blood (2020) 135 (15): 1287–1298.

DOI: https://doi.org/10.1182/blood.2019003186

Published: 2020

Includes: Supplemental data

Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC

Blood (2019) 134 (Supplement_1): 875.

DOI: https://doi.org/10.1182/blood-2019-123275

Published: 2019

Journal Articles

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Blood (2019) 134 (3): 304–316.

DOI: https://doi.org/10.1182/blood.2019000216

Published: 2019

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Children and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated at Investigator Discretion: A Report from Children's Oncology Group (COG) AALL0434

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Brent Wood, MD PhD, Zhiguo Chen, MS, Natia Esiashvili, MD, Barbara L Asselin, MD, Mignon L. Loh, MD, Karen R. Rabin, MD PhD, Elizabeth A. Raetz, MD, Patrick A. Zweidler-McKay, MD PhD, Kirk R. Schultz, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Kimberly P. Dunsmore, MD

Blood (2018) 132 (Supplement 1): 659.

DOI: https://doi.org/10.1182/blood-2018-99-112146

Published: 2018

Journal Articles

Provincial Disparities in Access to Allogeneic Transplant in Canada

Kristjan Paulson, MD, Oliver Bucher, Geoffrey Cuvelier, MD, Andrew Daly, MD, Alina S. Gerrie, MD MPH, David Sanford, MD, David Szwajcer, MD FRCP(C), Matthew Seftel, MRCP, MD MPH, FRCPC, Irwin Walker, MBBS, Natasha Kekre, MD FRCPC, Tony H Truong, MD FRCPC, Donna Wall, MD CCPE, Kirk R. Schultz, MD, Stephen Couban, MDBSc, Christopher Bredeson, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 4742.

DOI: https://doi.org/10.1182/blood-2018-99-113849

Published: 2018

Journal Articles

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

Blood (2018) 132 (13): 1438–1451.

DOI: https://doi.org/10.1182/blood-2018-01-828277

Published: 2018

Includes: Supplemental data

Journal Articles

Plerixafor effectively mobilizes CD56 bright NK cells in blood, providing an allograft predicted to protect against GVHD

Peggy P. C. Wong, Amina Kariminia, David Jones, Connie J. Eaves, Ronan Foley, Sabine Ivison, Stephen Couban, Kirk R. Schultz

Blood (2018) 131 (25): 2863–2866.

DOI: https://doi.org/10.1182/blood-2018-03-836700

Published: 2018

Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2017) 130 (Suppl_1): 98.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.98.98

Published: 2017

Journal Articles

Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes

Mary Eapen, MBBS, Joanne Kurtzberg, MD, Mei-Jie Zhang, PhD, Adam M. Mendizabal, PhD, Ka Wah Chang, MD, Michel Duval, MD, Mingwei Fei, MS, Steven Neudorf, MD, Satiro N. De Oliveira, MD, Donna A. Wall, MD, Kirk R. Schultz, MD, Mary M Horowitz, MD MS, John E. Wagner, MD

Blood (2016) 128 (22): 1231.

DOI: https://doi.org/10.1182/blood.V128.22.1231.1231

Published: 2016

Journal Articles

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3 + NK cells

Blood (2016) 127 (24): 3082–3091.

DOI: https://doi.org/10.1182/blood-2015-09-668251

Published: 2016

Includes: Supplemental data

Journal Articles

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach

Nobuko Hijiya, Kirk R. Schultz, Markus Metzler, Frederic Millot, Meinolf Suttorp

Blood (2016) 127 (4): 392–399.

DOI: https://doi.org/10.1182/blood-2015-06-648667

Published: 2016

Journal Articles

Genetic and Response-Based Risk Classification Identifies a Subgroup of NCI High Risk Childhood B-Lymphoblastic Leukemia (HR B-ALL) with Outstanding Outcomes: A Report from the Children's Oncology Group (COG)

Blood (2015) 126 (23): 807.

DOI: https://doi.org/10.1182/blood.V126.23.807.807

Published: 2015

Journal Articles

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients

Michael A. Pulsipher, Chris Carlson, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, Ilan Kirsch, Julie M. Gastier-Foster, Michael Borowitz, Cindy Desmarais, David Williamson, Michael Kalos, Stephan A. Grupp

Blood (2015) 125 (22): 3501–3508.

DOI: https://doi.org/10.1182/blood-2014-12-615757

Published: 2015

Includes: Supplemental data

Journal Articles

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Shernan G. Holtan, MD, Michael R. Verneris, MD, Kirk R. Schultz, MD, Laura Newell, MD, Gabrielle Meyers, MD, Fiona C. He, MD, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Sarah A. Cooley, MD MS, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 2489.

DOI: https://doi.org/10.1182/blood.V124.21.2489.2489

Published: 2014

NARROW

Circulating Cell Free Mitochondrial DNA As a Diagnostic and Prognostic Biomarker in Chronic and Late Acute Graft-Versus-Host Disease in Children

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Children and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated at Investigator Discretion: A Report from Children's Oncology Group (COG) AALL0434

Provincial Disparities in Access to Allogeneic Transplant in Canada

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

Plerixafor effectively mobilizes CD56 bright NK cells in blood, providing an allograft predicted to protect against GVHD

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3 + NK cells

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach

Genetic and Response-Based Risk Classification Identifies a Subgroup of NCI High Risk Childhood B-Lymphoblastic Leukemia (HR B-ALL) with Outstanding Outcomes: A Report from the Children's Oncology Group (COG)

IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only